SIST EN ISO 11737-1:2018 PDF
Sterilization of health care products - Microbiological methods - Part 1: Determination of a population of microorganisms on products (ISO 11737-1:2018)
Sterilization of health care products - Microbiological methods - Part 1: Determination of a population of microorganisms on products (ISO 11737-1:2018)
- Статус документа:
- Действующий
- Формат:
- Электронный (PDF)
- Количество страниц:
- 58
- Дата публикации:
- 19 марта 2018 г.
- ICS:
- 07.100.10
- Технический комитет:
- VAZ - Healthcare
ISO 11737-1:2018 specifies requirements and provides guidance on the enumeration and microbial characterization of the population of viable microorganisms on or in a health care product, component, raw material or package. NOTE 1 The nature and extent of microbial characterization is dependent on the intended use of bioburden data. NOTE 2 See Annex A for guidance on Clauses 1 to 9. ISO 11737-1:2018 does not apply to the enumeration or identification of viral, prion or protozoan contaminants. This includes the removal and detection of the causative agents of spongiform encephalopathies, such as scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. NOTE 3 Guidance on inactivating viruses and prions can be found in ISO 22442‑3, ICH Q5A(R1) and ISO 13022. ISO 11737-1:2018 does not apply to the microbiological monitoring of the environment in which health care products are manufactured.
Abstract
Overview
EN ISO 11737-1:2018 - Sterilization of health care products - Microbiological methods - Part 1: Determination of a population of microorganisms on products - defines requirements and guidance for the enumeration and microbial characterization of viable microorganisms (bioburden) on or in health care products, components, raw materials or packaging. It clarifies scope (excludes viral, prion and protozoan contaminants and environmental monitoring), emphasizes a risk‑based approach and provides annex guidance for method selection, validation and routine control.
Key topics and technical requirements
- Scope & exclusions: Applies to viable microorganism counts on products; does not apply to viruses, prions, protozoa or environmental monitoring of manufacturing areas.
- Method selection (Clauses 5–6): Choose appropriate sampling units and analytical techniques (direct plate counts, Most Probable Number (MPN), etc.) based on product type and intended use of data.
- Neutralization & removal: Account for inhibitory substances and ensure effective removal of microorganisms from the product matrix before culturing.
- Culturing & enumeration: Use validated culturing and counting procedures; handle direct plate counts, estimated counts and counts beyond ideal ranges per guidance.
- Microbial characterization: Tailor identification and extent of characterization to the purpose of bioburden data (e.g., sterilization validation vs routine QC).
- Validation (Clause 7): Validate methods for recovery efficiency and consider using correction factors (CF) where appropriate; Annex C explains validation of recovery efficiency.
- Limits of detection (LOD) & data use (Clause 8): Improve and interpret LOD, manage bioburden spikes as part of normal data, and apply suitable statistical methods and data analysis.
- Maintenance & requalification (Clause 9): Reassess methods after product or process changes and requalify as required.
- Informative annexes: Annex A–D provide guidance on implementation, methods, validation and responsibilities.
Practical applications & users
- Who uses it: Medical device and health care product manufacturers, microbiology laboratories, sterilization validation engineers, quality assurance and regulatory professionals.
- Why it's used: To generate defensible bioburden data for sterilization process development, routine product release, risk assessments and regulatory submissions. It supports decisions on sterilization cycles, packaging integrity testing (when integral to product), and supplier/raw‑material control.
- Benefits: Standardizes bioburden determination, improves comparability of results, informs sterilization validation and helps reduce risk of microbial survival.
Related standards
- EN ISO 11737-2 (sterilization - tests of sterilization efficacy)
- ISO 22442‑3, ICH Q5A(R1), ISO 13022 (guidance on inactivating viruses and prions)
Keywords: EN ISO 11737-1:2018, bioburden, sterilization, microbial characterization, bioburden recovery, limit of detection, MPN, health care products, sterilization validation.
Технические детали
- SKU
- SIST EN ISO 11737-1:2018
Похожие стандарты
Стандарты, упомянутые в описании
ISO 11737-1:2018
ДействующийSterilization of health care products — Microbiological methods — Part 1: Determination of a population of mi…
Overview ISO 11737-1:2018 - "Sterilization of health care products - Microbiological methods - Part 1: Determination of a population of microorganisms on products" defines requirements and guidance f…
SIST EN ISO 11737-2:2020
ДействующийSterilization of health care products - Microbiological methods - Part 2: Tests of sterility performed in the…
Overview EN ISO 11737-2:2020 - Sterilization of health care products - Microbiological methods - Part 2 (ISO 11737-2:2019) defines general criteria for tests of sterility used when defining, validati…
SIST EN ISO 22442-3:2008
ДействующийMedical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or…
Overview EN ISO 22442-3:2007 (ISO 22442-3:2007) defines requirements for the validation of elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents during m…
BS EN ISO 1302:2002
ОтменёнGeometrical product specifications (GPS). Indication of surface texture in technical product documentation
1 Scope This International Standard specifies the rules for the indication of surface texture in technical product documentation (e.g. drawings, specifications, contracts, reports) by means of graphi…